Published November 1979 | Published
Journal Article Open

Synthetic phospholipid vesicles containing a purified viral antigen and cell membrane proteins stimulate the development of cytotoxic T lymphocytes

An error occurred while generating the citation.

Abstract

Synthetic phospholipid vesicles (liposomes) containing the purified glycoprotein (G) of vesicular stomatitis virus (VSV) and solubilized membrane proteins from cells of the appropriate H-2 haplotype elicited H-2-restricted cytotoxic T lymphocytes (CTL) that lysed VSV-infected target cells. The CTL were elicited by intact liposomes, not by released components. Thus, when spleen cells from VSV-primed H-2d X H- 2b hybrid mice were stimulated with liposomes having G protein + membrane proteins from cells with one of the parental H-2 haplotypes, the resulting CTL lysed only VSV-infected target cells with that parent's H-2 type. This result argues against the view that T cells in general recognize only processed antigenic fragments on macrophages. Moreover, liposomes were only effective when G protein and cell membrane proteins were included in the same vesicles. This result suggests that for effective interaction with CTL precursors the antigen (G protein) and products of the H-2 complex must be closer to each other than 600-1,000 angstrom, the diameter of the lipid vesicles used in this study.

Additional Information

© 1979 by the Rockefeller University Press. RUP grants the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode. Received for publication 29 May 1979. Supported by Research grant CA-15472 and Center grant CA-14051 to the Massachusetts Institute of Technology, Center for Cancer Research, from the National Cancer Institute, and by a research grant from the American Cancer Society (IM-161), and the North Carolina United Way and Forsythe Cancer Service. Alonzo H. Ross is a Damon Runyon-Walter Winchell Cancer Fund Fellow (DRG-144-FT). David Baltimore is a Research Professor of the American Cancer Society.

Attached Files

Published - LOHjem79.pdf

Files

LOHjem79.pdf
Files (578.4 kB)
Name Size Download all
md5:0ea1c04597568dc7431c3bb18d5fc10c
578.4 kB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 17, 2023